HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James F Donohue Selected Research

Formoterol Fumarate (Oxis)

1/2021Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update.
1/2019Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT.
1/2019An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD.
1/2019Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base.
1/2018Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial.
1/2017A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
1/2017Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
1/2017Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease.
1/2017A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease.
1/2017Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James F Donohue Research Topics

Disease

82Chronic Obstructive Pulmonary Disease (COPD)
06/2021 - 07/2002
10Asthma (Bronchial Asthma)
06/2021 - 01/2004
9Dyspnea (Shortness of Breath)
01/2019 - 07/2002
5Inflammation (Inflammations)
10/2019 - 01/2004
4Obstructive Lung Diseases (Obstructive Lung Disease)
01/2019 - 03/2016
3Chronic Bronchitis
10/2019 - 12/2002
2Confusion (Bewilderment)
06/2019 - 10/2011
2Lung Diseases (Lung Disease)
01/2019 - 05/2007
2Sarcoidosis (Schaumann Disease)
10/2006 - 03/2004
1Metaplasia
10/2019
1Atrial Fibrillation
01/2019
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1Disease Progression
01/2017
1Bronchial Spasm
04/2016
1Cognitive Dysfunction
01/2014
1Heart Failure
09/2013
1Substance-Related Disorders (Drug Abuse)
09/2013
1Respiratory Insufficiency (Respiratory Failure)
09/2013
1Nasopharyngitis
01/2011
1Headache (Headaches)
01/2011
1Cardiac Arrhythmias (Arrythmia)
08/2008
1Neoplasms (Cancer)
05/2007
1Infections
05/2007
1Opportunistic Infections (Opportunistic Infection)
05/2007
1Pneumonia (Pneumonitis)
05/2007
1Cough
01/2006
1Oral Candidiasis (Thrush)
01/2004
1Lung Neoplasms (Lung Cancer)
12/2002

Drug/Important Bio-Agent (IBA)

36Bronchodilator Agents (Bronchodilators)IBA
06/2021 - 01/2004
23Formoterol Fumarate (Oxis)FDA Link
01/2021 - 04/2006
20Muscarinic AntagonistsIBA
06/2021 - 04/2011
19Adrenal Cortex Hormones (Corticosteroids)IBA
06/2021 - 01/2004
19Tiotropium Bromide (Spiriva)FDA Link
10/2019 - 07/2002
12Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric
01/2020 - 10/2013
10GSK573719IBA
03/2016 - 07/2012
9GoldIBA
05/2020 - 01/2014
9indacaterolIBA
01/2017 - 07/2010
8aclidinium bromideIBA
01/2021 - 04/2011
7SolutionsIBA
01/2019 - 12/2002
7vilanterolIBA
03/2016 - 07/2014
6revefenacinIBA
05/2020 - 01/2019
6Pharmaceutical PreparationsIBA
06/2019 - 12/2002
6Cholinergic Antagonists (Anticholinergics)IBA
01/2019 - 08/2004
5Salmeterol Xinafoate (Serevent)FDA Link
10/2013 - 07/2002
4Fluticasone-Salmeterol Drug Combination (Advair)FDA Link
06/2021 - 01/2004
4Ipratropium (Ipratropium Bromide)FDA LinkGeneric
04/2016 - 01/2004
3Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2020 - 07/2012
3Albuterol (Salbutamol)FDA LinkGeneric
04/2016 - 01/2004
2PowdersIBA
06/2021 - 08/2008
2Biomarkers (Surrogate Marker)IBA
01/2019 - 07/2013
2tartaric acid (tartrate)FDA Link
01/2017 - 12/2014
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2014 - 07/2013
2Levalbuterol (Xopenex)FDA LinkGeneric
01/2008 - 08/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2007 - 10/2006
2Infliximab (Remicade)FDA Link
05/2007 - 10/2006
1Therapeutic UsesIBA
10/2019
1GuaifenesinFDA LinkGeneric
10/2019
1Cholinergic Agents (Cholinergics)IBA
01/2019
1omega-Chloroacetophenone (Mace)IBA
01/2019
1Drug CombinationsIBA
06/2018
1Indicators and Reagents (Reagents)IBA
06/2018
1Biological FactorsIBA
01/2017
1Dihydrotachysterol (AT 10)IBA
05/2015
1Cytokine Receptors (Cytokine Receptor)IBA
05/2015
12- hydroxy- N,N- dimethyl- 3- (2- ((1- (5- methylfuran- 2- yl)propyl)amino)- 3,4- dioxocyclobut- 1- enylamino)benzamideIBA
05/2015
1Mometasone Furoate (Nasonex)FDA LinkGeneric
02/2015
1maleic acid (maleate)IBA
02/2015
1QMF149IBA
02/2015
1BromidesIBA
02/2015
13- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA
09/2014
1Oxygen (Dioxygen)IBA
09/2013
1N 556IBA
01/2011
1carmoterolIBA
06/2010
1Air Pollutants (Pollutants, Air)IBA
02/2010
1SmokeIBA
02/2010
1Glucose (Dextrose)FDA LinkGeneric
08/2008
1PotassiumIBA
08/2008
1Biological ProductsIBA
01/2008
1Anti-Bacterial Agents (Antibiotics)IBA
05/2007
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
04/2006
1AerosolsIBA
01/2006
1Theophylline (Theon)FDA LinkGeneric
04/2005
1Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
08/2004
1Phosphodiesterase InhibitorsIBA
08/2004
1SteroidsIBA
08/2004
1Uridine Triphosphate (UTP)IBA
12/2002

Therapy/Procedure

31Therapeutics
06/2021 - 01/2004
11Nebulizers and Vaporizers (Inhaler)
05/2020 - 08/2010
8Metered Dose Inhalers (Metered Dose Inhaler)
01/2017 - 07/2002
4Dry Powder Inhalers
01/2017 - 07/2002
1Drug Therapy (Chemotherapy)
11/2020
1Aftercare (After-Treatment)
01/2017
1Duration of Therapy
08/2010
1Gamma Cameras (Gamma Camera)
01/2006